Real-World Evidence & Trials Masterclass Series 2021
OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies and their pros and cons compared with trials.
Real-World Evidence (RWE) is a key opportunity to better understand the diseases and patient needs. Besides, all RWE projects, except pragmatic trials, share the same scientific methodology as observational research. Thus, during these 4 monthly one-hour sessions, starting in March 2021, the attendees will learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and Nawab Qizilbash, epidemiologist and clinician.
They will lead this Masterclass series, presenting the different topics in clear non-technical terms and illustrating them with examples from drugs and devices in multiple therapy areas.
Thus, if you are in Epidemiology, HEOR, Safety, Statistics, Medical Affairs, Market Access, Marketing, Project Management or Outsourcing in a biopharmaceutical or device company, don’t miss out on your chance to learn from leading experts.
See below our live sessions for you to register for any or all masterclasses.
Session 1: Non-randomized Comparative Effectiveness Studies: ‘The magic of randomization and the reality of Real-World Evidence studies’
On Wednesday, 17 March 2021 at 5-6 pm CET
Session 2: The Tyranny of Propensity Scores: The good and the bad
On Wednesday, 21 April 2021 at 5-6 pm CEST
Session 3: Non-randomized Comparative Safety Studies
On Wednesday, 19 May 2021 at 5-6 pm CEST
Session 4: Individualizing Benefit-Risk
On Wednesday, 16 June 2021 at 5-6 pm CEST